Costs of Hospital Events in Patients with Metastatic Colorectal Cancer

被引：0
|
作者：
Overbeek, Jetty A. [1 ]
Zhao, Zhongyun [2 ]
van Herk-Sukel, Myrthe P. P. [1 ]
Barber, Beth L. [2 ]
Gao, Sue [2 ]
Herings, Ron M. C. [1 ,3 ]
机构：
[1] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Erasmus MC, Rotterdam, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
635
引用
收藏
页码：S277 / S277
页数：1
相关论文
共 50 条
  • [41] Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia
    Goldsbury, David E.
    Feletto, Eleonora
    Weber, Marianne F.
    Haywood, Philip
    Pearce, Alison
    Lew, Jie-Bin
    Worthington, Joachim
    He, Emily
    Steinberg, Julia
    O'Connell, Dianne L.
    Canfell, Karen
    PLOS ONE, 2021, 16 (11):
  • [42] Utilization profiles and costs of cetuximab in the taking charge of colorectal metastatic cancer
    Ruhmann, A.
    Perrier-Cornet, E.
    Serra, S.
    Palascak, V
    Ben Abdelgheni, M.
    Beretz, L.
    Bergerat, J. P.
    Kurtz, J. E.
    Leveque, D.
    BULLETIN DU CANCER, 2007, 94 (06) : 588 - 588
  • [43] Adverse events and costs among non-metastatic castration-resistant prostate cancer patients
    Appukkuttan, Sreevalsa
    Yao, Jianying
    Partridge, Jamie
    Kong, Sheldon X.
    Parkin, Jacqueline
    Freedland, Stephen J.
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 145 - 152
  • [44] Costs and resource utilization associated with skeletal related events in Medicare patients with prostate cancer metastatic to bones
    McDougall, Jean A.
    Goulart, Bernardo
    Bansal, Aasthaa
    Sullivan, Sean D.
    McCune, Jeannine S.
    Karnopp, Andrew
    Fedorenko, Catherine R.
    Valdarrama, Adriana
    Ramsey, Scott David
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Survival and lifetime costs associated with first-line bevacizumab in older patients with metastatic colorectal cancer
    Shankaran, V.
    Mummy, D.
    Koepl, L.
    Mirick, D.
    Yu, E.
    Morlock, R.
    Ramsey, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S328 - S328
  • [46] Hospital readmissions after liver surgery for metastatic colorectal cancer
    Tamandl, Dietmar
    Butte, Jean M.
    Allen, Peter J.
    D'Angelica, Michael I.
    DeMatteo, Ronald P.
    Groeger, Jeffrey S.
    Jarnagin, William R.
    Fong, Yuman
    SURGERY, 2015, 157 (02) : 231 - 238
  • [47] Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study
    Ljunggren, Malin
    Weibull, Caroline E.
    Rosander, Emma
    Palmer, Gabriella
    Glimelius, Bengt
    Martling, Anna
    Nordenvall, Caroline
    BMC CANCER, 2022, 22 (01)
  • [48] Outcome of metastatic colorectal cancer patients receiving second line chemotherapy in Marmara University Hospital
    Dane, F.
    Gumus, M.
    Ozturk, A.
    Yumuk, F.
    Iyikesici, S.
    Basaran, G.
    Cabuk, D.
    Teomete, M.
    Turhal, N. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study
    Malin Ljunggren
    Caroline E. Weibull
    Emma Rosander
    Gabriella Palmer
    Bengt Glimelius
    Anna Martling
    Caroline Nordenvall
    BMC Cancer, 22
  • [50] Induction therapy in patients with metastatic colorectal cancer
    Venook, AP
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 25 - 29
12345